| Accession Number: | 0001104659-21-088377 |
| Date: | 2021-07-01 |
| Issuer: | SPRINGWORKS THERAPEUTICS, INC. (SWTX) |
| Original Submission Date: |
EDRIS BADREDDIN
C/O SPRINGWORKS THERAPEUTICS, INC.
100 WASHINGTON BLVD.
STAMFORD, CT 06902
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-07-01 | S | 32,000 | d | $85.35 | 301,541 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the sales reported on this form 4 were effected pursuant to a trading plan adopted pursuant to rule 10b5-1 under the securities exchange act of 1934, as amended. |
| f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions in prices ranging from $82.01 to $87.12, inclusive |
| f3 | includes 101,038 restricted stock awards subject to time-based vesting. |
